Finance

Lists
Why is TNGX up 5,85%?
Dive Deeper
TNGX:NASDAQ
Tango Therapeutics Inc
23,89 US$
+5,85%
(+1,32) 1D
9 ოქტ, 13:29:44 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNGX...
Open
22,60 US$
High
24,12 US$
Low
22,44 US$
Mkt. cap
4,03 მლრდ.
Avg. vol.
3,05 მლნ.
Volume
1,27 მლნ.
52-wk high
34,39 US$
52-wk low
6,69 US$
EPS
-0,84 US$
Beta
1,17
Shares outstanding
168,61 მლნ.
No. of employees
137
Open
22,60 US$
High
24,12 US$
Low
22,44 US$
Mkt. cap
4,03 მლრდ.
Avg. vol.
3,05 მლნ.
Volume
1,27 მლნ.
52-wk high
34,39 US$
52-wk low
6,69 US$
EPS
-0,84 US$
Beta
1,17
Shares outstanding
168,61 მლნ.
No. of employees
137
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
22 საათის წინ
(TNGX) Movement as an Input in Quant Signal Sets
About Tango Therapeutics Inc
CEO-
Employees137
Founded2017
Headquartersბოსტონი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to TNGX in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TNGX in the last 3 months.
Highest
Current 23,89 US$
68,00 US$ (+184,64%)
Average
42,57 US$ (+78,19%)
Lowest
24,00 US$ (+0,46%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
46,00 US$
+92,5%
10/08/2026
Kelsey Goodwin
Piper Sandler
Hold
Maintained
24,00 US$
+0,5%
10/01/2026
Michael Schmidt
Guggenheim
Buy
Maintained
35,00 US$
+46,5%
09/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
68,00 US$
+184,6%
08/18/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
40,00 US$
+67,4%
08/17/2026
Robert Driscoll
Wedbush
Buy
Reiterated
39,00 US$
+63,2%
08/12/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
40,00 US$
+67,4%
07/17/2026
Brian Cheng
J.P. Morgan
Buy
Initiated
46,00 US$
+92,5%
07/15/2026
Maury Raycroft
Jefferies
Buy
Upgraded
60,00 US$
+151,2%
06/26/2026
Kalpit Patel
Wolfe Research
Buy
Upgraded
35,00 US$
+46,5%
06/08/2026
Yuan Zhi
B. Riley Securities
Buy
Reiterated
35,00 US$
+46,5%
06/09/2026
Unknown Analyst
Guggenheim
Buy
Maintained
32,00 US$
+33,9%
06/01/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
55,00 US$
+130,2%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
53,81 მლნ.
-
-
-
Cost of goods sold
30,82 მლნ.
32,10 მლნ.
33,53 მლნ.
37,20 მლნ.
Cost of revenue
30,82 მლნ.
32,10 მლნ.
33,53 მლნ.
37,20 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,92 მლნ.
9,76 მლნ.
15,24 მლნ.
22,59 მლნ.
Operating expense
8,92 მლნ.
9,76 მლნ.
15,24 მლნ.
22,59 მლნ.
Total operating expenses
39,74 მლნ.
41,86 მლნ.
48,77 მლნ.
59,78 მლნ.
Operating income
14,07 მლნ.
-41,86 მლნ.
-48,77 მლნ.
-59,78 მლნ.
Other non operating income
705,00 ათ.
3,30 მლნ.
-45,00 ათ.
722,00 ათ.
EBT including unusual items
15,87 მლნ.
-38,80 მლნ.
-45,51 მლნ.
-55,34 მლნ.
EBT excluding unusual items
15,87 მლნ.
-36,88 მლნ.
-46,64 მლნ.
-55,34 მლნ.
Income tax expense
-10,00 ათ.
-55,00 ათ.
1,00 ათ.
1,00 ათ.
Effective tax rate
-0,06%
0,14%
-
-
Other operating expenses
-
-
-
-
Net income
15,88 მლნ.
-38,75 მლნ.
-45,51 მლნ.
-55,34 მლნ.
Net profit margin
29,52%
-
-
-
Earnings per share
0,13
-0,29
-0,32
-0,37
Interest and investment income
1,10 მლნ.
1,68 მლნ.
2,18 მლნ.
3,72 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,10 მლნ.
1,68 მლნ.
2,18 მლნ.
3,72 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
14,63 მლნ.
-41,38 მლნ.
-48,31 მლნ.
-59,36 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები